Volume 28, Number 10—October 2022
Research Letter
Introduction and Differential Diagnosis of Monkeypox in Argentina, 2022
Adrian Lewis, Alejandro Josiowicz, Stella Maris Hirmas Riade, Monica Tous, Gustavo Palacios1, and Daniel M. Cisterna1
Table
Characteristics of suspected cases of monkeypox in Argentina and Bolivia*
| Patient no. |
Age, y/sex | Clinical manifestations | Country | Travel history |
Hospital admission |
Background | MPXV PCR |
EV PCR/EV type | HSV PCR |
VZV PCR |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
40/M |
Pustular lesions on the left shoulder, sternal, cervical, right scapula, left lower limb, multiple painful intergluteal and perianal lesions |
Argentina |
Spain |
Yes |
Multiple sexual partners, HIV+ |
+ |
ND |
ND |
ND |
| 2 |
40/M |
Genital ulcer |
Argentina |
Spain |
No |
Multiple sexual partners |
+ |
ND |
ND |
ND |
| 3 |
36/M |
Fever, headache, myalgia, back pain, maculopapular lesions and pustules |
Argentina |
No reported travel |
Yes |
Multiple sexual partners |
+ |
ND |
ND |
ND |
| 4 |
36/M |
Vesicular lesions on
the palms, soles,
and perineum |
Argentina |
Dominican Republic |
No |
3-year-old son with blistering lesion on the perineum |
– |
– |
– |
– |
| 5 |
43/M |
Fever, maculopapular lesions and pustules |
Argentina |
Paraguay |
No |
No data |
– |
+/CV-A6 |
– |
– |
| 6 |
39/F |
Vesicular lesions
on hand, mouth,
and groin area |
Argentina |
Dominican Republic and Colombia |
No |
No data |
– |
+/CV-A6 |
– |
– |
| 7 |
53/F |
Exanthematous lesions of unspecified distribution, lymphadenopathy |
Bolivia |
No reported travel |
No |
No data |
– |
– |
– |
– |
| 8 |
22/F |
Exanthematous lesions of unspecified distribution, lymphadenopathy |
Bolivia |
Spain |
No |
No data |
– |
+/CV-A6 |
– |
– |
| 9 | 27/M | Exanthematous lesions of unspecified distribution, lymphadenopathy | Bolivia | No reported travel | No | HIV+ | – | +/ND | – | – |
*CV-A6, coxsackievirus A6; EV, enterovirus; HSV, herpes simplex virus; MPXV, monkeypox virus; ND, not done; VZV, varicella zoster virus; +, positive; –, negative.
1These authors were co–principal investigators.
Page created: August 02, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.